Sanofi Files New Pompe Hope Avalglucosidase Alfa In EU

Review Is Standard, Not Accelerated As Requested

 
• By Kevin Grogan
  
Lyon France, 3 October 2017: White logo of the french multinational pharmaceutical company Sanofi on their glass office building in Lyon France
Sanofi Looks To Keep The Lead In Pompe Disease • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Rare Diseases

More from Scrip